AAAAAA

   
Results: 1-8 |
Results: 8
Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain
Authors: Cocuzza, AJ Chidester, DR Cordova, BC Jeffrey, S Parsons, RL Bacheler, LT Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: Aj. Cocuzza et al., Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain, BIOORG MED, 11(9), 2001, pp. 1177-1179
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Rodgers, JD
Citation: M. Patel et al., Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 11(14), 2001, pp. 1943-1945
DPC 681 and DPC 684: Potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants
Authors: Kaltenbach, RF Trainor, G Getman, D Harris, G Garber, S Cordova, B Bacheler, L Jeffrey, S Logue, K Cawood, P Klabe, R Diamond, S Davies, M Saye, J Jona, J Erickson-Viitanen, S
Citation: Rf. Kaltenbach et al., DPC 681 and DPC 684: Potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants, ANTIM AG CH, 45(11), 2001, pp. 3021-3028
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Rodgers, JD
Citation: M. Patel et al., Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 10(15), 2000, pp. 1729-1731
Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIVtype 1 replication in microglia in vitro
Authors: Albright, AV Erickson-Viitanen, S O'Connor, M Frank, I Rayner, MM Gonzalez-Scarano, F
Citation: Av. Albright et al., Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIVtype 1 replication in microglia in vitro, AIDS RES H, 16(15), 2000, pp. 1527-1537
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents
Authors: Patel, M Rodgers, JD McHugh, RJ Johnson, BL Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Ko, SS
Citation: M. Patel et al., Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents, BIOORG MED, 9(22), 1999, pp. 3217-3220
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA (TM))
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: M. Patel et al., Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA (TM)), BIOORG MED, 9(22), 1999, pp. 3221-3224
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M Ko, SS McHugh, RJ Markwalder, JA Srivastava, AS Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Seitz, SP
Citation: M. Patel et al., Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 9(19), 1999, pp. 2805-2810
Risultati: 1-8 |